Product Name:Frag 176 191
Synonyms: Fragment 176-191, AOD-9604
MF: C78H123N23O23S2
MW: 1815.08152
CAS:221231-10-3
Purity:Above 98%
Packing:2mg/vial and 5mg/vial;10vials/box
Appearance: White lyophilized powder
Method of Analysis: HPLC
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C.
HGH fragment 176-191 Reviews
Growth Hormone peptide fragment 176-191,also known as HGH Frag 176-191 is a modified form of amino acids 176-191 of the GH polypeptide. Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one end of the Growth Hormone molecule. This region, which consists of amino acids 176-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance. It works by mimicking the way natural Growth Hormone regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified Growth Hormone. Like Growth Hormone, the hgH fragment 176-191 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (the transformation of nonfat food materials into body fat) both in laboratory testing and in animals and humans.
HGH fragment 176-191 is a fat loss peptide derived from the GH molecule, which directly initiates lipolysis and inhibits lipogenesis, but in order to better understand this peptide, it is imperative to have at least a rudimentary understanding of its parent hormone .
It acts on the reduction of excessive adipose tissues such as increase in muscle mass, and enhances the lipid content of the body.
GH is a polypeptide which contains an amino acid sequence that is 191 amino acids in length. HGH fragment 176-191 was developed by isolating and modifying the specific portion of the GH molecule responsible for thehormone\\\'s lipolytic and anti-lipogenic effects.
The portion of the molecule responsible for these effects is amino acids 176/191. In every sense, Frag should primarily be considered a fat loss peptide which performs these functions through the same pathways as traditional GH, but without exposing the user to the potentially undesirable side effects which may present themselves during GH administration.
| CAS | 221231-10-3 |
| MF | C78H123N23O23S2 |
